ARTICLE | Clinical News
LAU-7b: Phase Ib data
July 20, 2015 7:00 AM UTC
Top-line data from a double-blind, placebo-controlled, Canadian Phase Ib trial in 15 adult CF patients chronically infected with Pseudomonas aeruginosa showed that once-daily 100, 200 and 300 mg doses...